Znanstveni rad - Izvorni znanstveni rad
Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination—are we exploiting their full potential in a real life setting?
World Journal of Diabetes, 11 (2020), 11; 540-552. https://doi.org/10.4239/wjd.v11.i11.540

Berković, Maja Cigrovski; Bilić-Čurčić, Ines; Božek, Tomislav; Mahecic, Davorka Herman; Klobučar Majanović, Sanja; Canecki-Varžić, Silvija; Andrić, Jelena; Marušic, Srećko; Mrzljak, Anna

Citirajte ovaj rad

Berković, M. C., Bilić Čurčić, I., Božek, T., Mahecic, D. H., Klobučar Majanović, S., Canecki Varžić, S. ... Mrzljak, A. (2020). Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination—are we exploiting their full potential in a real life setting?. World Journal of Diabetes, 11. (11), 540-552. doi: 10.4239/wjd.v11.i11.540

Berković, Maja Cigrovski, et al. "Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination—are we exploiting their full potential in a real life setting?." World Journal of Diabetes, vol. 11, br. 11, 2020, str. 540-552. https://doi.org/10.4239/wjd.v11.i11.540

Berković, Maja Cigrovski, Ines Bilić Čurčić, Tomislav Božek, Davorka Herman Mahecic, Sanja Klobučar Majanović, Silvija Canecki Varžić, Jelena Andrić, Srećko Marušic i Anna Mrzljak. "Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination—are we exploiting their full potential in a real life setting?." World Journal of Diabetes 11, br. 11 (2020): 540-552. https://doi.org/10.4239/wjd.v11.i11.540

Berković, M. C., et al. (2020) 'Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination—are we exploiting their full potential in a real life setting?', World Journal of Diabetes, 11(11), str. 540-552. doi: 10.4239/wjd.v11.i11.540

Berković MC, Bilić Čurčić I, Božek T, Mahecic DH, Klobučar Majanović S, Canecki Varžić S, i sur.. Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination—are we exploiting their full potential in a real life setting?. World Journal of Diabetes [Internet]. 15.11.2020. [pristupljeno 18.06.2021.];11(11):540-552. doi: 10.4239/wjd.v11.i11.540

M. C. Berković, et al., "Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination—are we exploiting their full potential in a real life setting?", World Journal of Diabetes, vol. 11, br. 11, str. 540-552, Studeni 2020. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:215648. [Citirano: 18.06.2021.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.